Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TenNor Therapeutics
company
About
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥264M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥264M $25M
TenNor Therapeutics has raised a total of
¥264M $25M
in funding over 2 rounds. Their latest funding was raised on
Mar 30, 2022 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 30, 2022 | Series D | ¥264M | 1 | — | — | Detail |
| Sep 19, 2016 | Series B | $25M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
TenNor Therapeutics is funded by 2 investors.
Zhongnuo Venture Capital
and Relativity Healthcare Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
